Reuters - U.S. health advisers said they were unconvinced that Teva Pharmaceutical Industries Ltd's Parkinson's drug Azilect slows the progression of the incurable disease.
You are here:
Health 
Diseases & Conditions U.S. advisers doubt Teva Parkinson's drug claim
(Reuters)
Diseases & Conditions U.S. advisers doubt Teva Parkinson's drug claim
(Reuters)
